Publication

The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Michael P. Madaio, Augusta UniversityIstvan Czikora, Augusta UniversityNino Kvirkvelia, Augusta UniversityMalgorzata McMenamin, Augusta UniversityQiang Yue, Emory UniversityTing Liu, Augusta UniversityHaroldo Toque, Augusta UniversitySupriya Sridhar, Augusta UniversityKatherine Covington, Augusta UniversityRabei Alaisami, Augusta UniversityPaul O'Connor, Augusta UniversityRobert W. Caldwell, Augusta UniversityJian-Kang Chen, Augusta UniversityMatthias Claus, Indiana Center for Vascular Biology and MedicineMichael W. Brands, Augusta UniversityDouglas Eaton, Emory UniversityMaritza Romero, Augusta UniversityRudolf Lucas, Augusta University
Language
  • English
Date
  • 2019-06-01
Publisher
  • Elsevier Science Inc.
Publication Version
Copyright Statement
  • © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 95
Issue
  • 6
Start Page
  • 1359
End Page
  • 1372
Grant/Funding Information
  • This work was supported by grants R01 DK100564 (MPM, RL), DK37963 (DCE), DK099548 (POC) and DK114328 (JKC) from the NIH/NIDDK, as well as grants R01 HL138410 (RL), HL128207 (MB) and HL129843 (MC) and P01 HL134604 (MB, POC) from the NIH/NHLBI and grants 17GRNT33410653 from the AHA (MJR), Innovative Grant 1-INO-2017–459-A-N from the JDRF (MJR) and grant #1–16-IBS-196 from the ADA (RL).
Supplemental Material (URL)
Abstract
  • In mice, the initial stage of nephrotoxic serum-induced nephritis (NTN) mimics antibody-mediated human glomerulonephritis. Local immune deposits generate tumor necrosis factor (TNF), which activates pro-inflammatory pathways in glomerular endothelial cells (GECs) and podocytes. Because TNF receptors mediate antibacterial defense, existing anti-TNF therapies can promote infection; however, we have previously demonstrated that different functional domains of TNF may have opposing effects. The TIP peptide mimics the lectin-like domain of TNF, and has been shown to blunt inflammation in acute lung injury without impairing TNF receptor-mediated antibacterial activity. We evaluated the impact of TIP peptide in NTN. Intraperitoneal administration of TIP peptide reduced inflammation, proteinuria, and blood urea nitrogen. The protective effect was blocked by the cyclooxygenase inhibitor indomethacin, indicating involvement of prostaglandins. Targeted glomerular delivery of TIP peptide improved pathology in moderate NTN and reduced mortality in severe NTN, indicating a local protective effect. We show that TIP peptide activates the epithelial sodium channel(ENaC), which is expressed by GEC, upon binding to the channel's α subunit. In vitro, TNF treatment of GEC activated pro-inflammatory pathways and decreased the generation of prostaglandin E2 and nitric oxide, which promote recovery from NTN. TIP peptide counteracted these effects. Despite the capacity of TIP peptide to activate ENaC, it did not increase mean arterial blood pressure in mice. In the later autologous phase of NTN, TIP peptide blunted the infiltration of Th17 cells. By countering the deleterious effects of TNF through direct actions in GEC, TIP peptide could provide a novel strategy to treat glomerular inflammation.
Author Notes
  • Correspondence: Rudolf Lucas, PhD (corresponding author), Vascular Biology Center, Department of Pharmacology and Toxicology, office CB3213B, Medical College of Georgia at Augusta University, Augusta, GA 30912, rlucas@augusta.edu Phone: 706 721 9470, Fax: 706 721 9799
Keywords
Research Categories
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items